Selank + Semax
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Selank+Semax
SK+XA,ChemSpider 9940290 · CAS 129954-34-3,Wikipedia · CAS 80714-61-0

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of tuftsin; Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of an ACTH fragment. Both contain a C-terminal Pro-Gly-Pro extension and are supplied for laboratory research.
Overview
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from the endogenous tetrapeptide tuftsin by addition of a C-terminal Pro-Gly-Pro motif.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, corresponding to a modified ACTH fragment with the same C-terminal Pro-Gly-Pro extension.
Both peptides are provided as lyophilized research materials with full analytical documentation.
What are Selank and Semax?
Selank (CAS 129954-34-3) is a seven-residue peptide (H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH) with molecular formula C33H57N11O9 and average molecular weight approximately 751.9 g/mol. It is a structural analogue of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) extended by Pro-Gly-Pro. Semax (CAS 80714-61-0) is a seven-residue peptide (H-Met-Glu-His-Phe-Pro-Gly-Pro-OH) with molecular formula C37H51N9O10S and average molecular weight approximately 813.9 g/mol. It is a synthetic analogue of an ACTH fragment incorporating the same C-terminal Pro-Gly-Pro sequence.
Structural features
Both peptides are linear heptapeptides containing three proline residues and the shared C-terminal Pro-Gly-Pro motif. Selank contains basic residues (Lys, Arg); Semax contains a methionine residue and an acidic residue (Glu). Neither contains cysteine or disulfide bonds.
Characterization
Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the Certificate of Analysis.
Key Highlights
- Synthetic heptapeptides for laboratory research
- Selank: tuftsin analogue, sequence TKPRPGP (CAS 129954-34-3)
- Semax: ACTH-fragment analogue, sequence MEHFPGP (CAS 80714-61-0)
- Shared C-terminal Pro-Gly-Pro structural motif
- ≥99% purity verified by HPLC & Mass Spectrometry
- Lyophilized solid peptides
- Research-grade material
Safety & Side Effects
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of tuftsin; Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of an ACTH fragment. Both contain a C-terminal Pro-Gly-Pro extension and are supplied for laboratory research. When used in research, Selank + Semax should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published selank + semax side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for neurological and neuroprotective pathways readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for Selank + Semax; it is supplied strictly for laboratory research. Reported selank + semax dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document selank + semax dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS Selank: 129954-34-3 Semax: 80714-61-0 分子式, molecular formula Selank: C33H57N11O9 Semax: C37H51N9O10S, molecular weight Selank: 751.9 g/mol Semax: 813.9 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| Peptide | Sequence | Molecular weight |
|---|---|---|
| Selank | Thr-Lys-Pro-Arg-Pro-Gly-Pro | 751.9 g/mol |
| Semax | Met-Glu-His-Phe-Pro-Gly-Pro | 813.9 g/mol |
How to Order
Enquiry
Send strength and quantity for a quote.
Quotation
Price, lead time and specification confirmed.
QC & COA
HPLC/LC‑MS tested; COA issued.
Delivery
Tracked worldwide shipping.
Specifications
| Product name | Selank+Semax |
|---|---|
| Product code | XK10 |
| Specification | 10mg*10vials |
| CAS number | Selank: 129954-34-3 Semax: 80714-61-0 分子式 |
| Molecular formula | Selank: C33H57N11O9 Semax: C37H51N9O10S |
| Molecular weight | Selank: 751.9 g/mol Semax: 813.9 g/mol |
| Purity | ≥99% (subject to batch COA) |
| Physical Form | Lyophilized white to off-white solid powder |
| Solubility | Soluble in bacteriostatic water |
| Amino Acid Count | 7 residues each |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized at −20 °C, protected from light and moisture. Bring to room temperature before opening. After reconstitution, refrigerate and avoid repeated freeze-thaw cycles.
Additional information
| Specification | 10mg*10vials, 20mg*10vials |
|---|


